BioAtla, Inc. (BCAB) vs 4D Molecular Therapeutics, Inc. (FDMT)
Detailed comparison between BioAtla, Inc., 4D Molecular Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)4D Molecular Therapeutics, Inc. (FDMT)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
4D Molecular Therapeutics, Inc.
FDMT
| Metric | BioAtla, Inc. (BCAB) | 4D Molecular Therapeutics, Inc. (FDMT) |
|---|---|---|
| Current Price | $0.38 | $4.52 |
| Change | -0.03 (-6.84%) | -0.12 (-2.59%) |
| Market Cap | $0.02B | $0.21B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.26 | -1.37 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $4.02 | $36.25 |
| 52-Week Low | $0.38 | $4.41 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.70 | $-2.85 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | -22.57% | -22.57% | -84.61% | -98.77% | -98.77% | -98.77% |
| FDMT | -4.24% | -4.24% | -84.41% | -88.84% | -88.84% | -88.84% |